A. Ernest Toth Jr.
Chief Financial Officer · Aquestive Therapeutics, Inc.
- 2026
- May 7, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies A. Ernest Toth Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Barber - $1.33M in AQST purchases and sales in the last 12 months
- Cassie Jung - $191K in AQST purchases and sales in the last 12 months
- Lori J. Braender - $167K in AQST purchases and sales in the last 12 months
- Julie Krop - $125K in AQST purchases and sales in the last 12 months
- Peter E. Boyd - $124K in AQST purchases and sales in the last 12 months
- Sherry Korczynski - $111K in AQST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is A. Ernest Toth Jr.?
A. Ernest Toth Jr. is a corporate insider, tracked as Chief Financial Officer of Aquestive Therapeutics, Inc. (AQST). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did A. Ernest Toth Jr. last file a Form 4?
The most recent primary Form 4 on record is dated 7 May 2026, one of 3 filings going back to 2026.
Has A. Ernest Toth Jr. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($243K) across all tracked filings.
